ArticleSe pu = Chinese journal of chromatography2023
[Coupling capillary electrophoresis-electrospray ionization mass spectrometry with sheathless interface for drug analysis].
Article in Se pu = Chinese journal of chromatography, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [Highly sensitive detection of fluorescent whitening agents in flour using sheathless capillary electrophoresis-electrospray ionization-tandem mass spectrometry].Se pu = Chinese journal of chromatography · 2024Article
- [Annual review of capillary electrophoresis technology in 2023].Se pu = Chinese journal of chromatography · 2024Review
- [Preparation of porous organic cage and its use as chiral stationary phase for capillary electrochromatography].Se pu = Chinese journal of chromatography · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capillary electrophoresis-mass spectrometry (CE-MS) combines the advantages of capillary electrophoresis, such as the high separation efficiency and low sample consumption, and the high detection sensitivity of mass spectrometry and the ability for providing the structural information for structure elucidation of unknown components. However, the interface technology for coupling capillary electrophoresis and mass spectrometry is still not well resolved. In the present work, we explored the application of the sheathless CE-MS interface which was prepared by gold foil-wrapped CE separation column tip directly as a spray electrode for the analysis of five tyrosine kinase inhibitors, namely sunitinib, imatinib mesylate, gefitinib, dasatinib and erlotinib. This interface integrates separation and electrospray ionization in one capillary, which is easy to manufacture, low in cost, and can be produced in batches. We found that using the nonaqueous CE separation mode can not only achieve baseline separation of five tyrosine kinase inhibitors, but also obtain stable mass spectrometry signals. First, we investigated the effect of the electrolyte solution composition on the separation. The optimized background electrolyte composition was obtained: 2% (v/v) acetic acid and 5 mmol/L ammonium acetate in acetonitrile-methanol (80∶20, v/v). Under optimized conditions, the five kinase inhibitors could be baseline separated, meantime, the sheathless interface could also maintain stable electrospray for a long time. The relative standard deviation (RSD) values of the intraday and interday repeatability of the analyte retention times were less than 0.5% and 0.8%, respectively, and the RSD value between interface batches is less than 2.6%. Compared with CE-MS with aqueous phase, the separation column efficiency of the five tyrosine kinase inhibitors under nonaqueous phase conditions is higher, the detection sensitivity is higher, and the absolute detection limit reaches amol level. In addition, we evaluated the sheathless interface with various organic acids, such as palaflin A, salvianolic acid C, and rosmarinic acid, as well as hydrophobic macrolide antibiotics, azithromycin, erythromycin, and sporin A, good separation effect and mass spectrometric detection results can be obtained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.